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• Maternal separation (MS) provoked depressive-like behaviors
• Selegiline exerted antidepressant-like effects in MS mice
• Effect of selegiline on the passive behaviors is mediated via D1 receptor
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Available online 30 April 2016Mother-infant interactions are known to be associated with the psychological well-being of an individual in
adulthood. It is well accepted that emotional stress in early life, such as maternal separation (MS), leads to alter-
ations in the neurotransmission systems of various brain regions, especially the mesolimbic dopaminergic sys-
tem, and subsequently can increase the risk for development of psychiatric disorders including depression in
adulthood. Selegiline is an irreversiblemonoamine oxidase (MAO) type B inhibitor which increases striatal dopa-
mine levels and exerts an antidepressant effect. In this study, 180 min of MS stress was applied to mice at post-
natal day (PND) 2–14 followed by behavioral tests for determining depressive-like behaviors, such as forced
swimming test (FST), splash test and sucrose preference test (SPT) in adult mice (PND 50). The open ﬁeld test
(OFT) also was applied to validate FST results. We used SCH23390 (D1 antagonist) and sulpiride (D2 antagonist)
in order to determine the role of D1 and D2 dopamine receptors in antidepressant-like effects of selegiline. Our
results revealed that MS provoked depressive-like behaviors in adult male mice, and the administration of
selegiline attenuated depressive-like behaviors inMSmice. Our ﬁndings showed that D1 dopamine receptors fa-
cilitate the positive effects of selegiline on the passive behavior in the FST. Furthermore, antidepressant effects of
selegiline on hedonic difﬁculties are mediated via D2 receptor in the SPT. The results of the splash test revealed
that both D1 and D2 receptorsmediate the protective effect of selegiline againstmotivational and self-care prob-
lems. Based on our results, we conclude that both D1 and D2 dopamine receptors are involved in mediating the
antidepressant-like effect of selegiline.We found that D1 receptorsmediate an effect on despair behavior, D2 re-
ceptors mediate an effect on anhedonia, and both D1 and D2 receptors contribute to the protective effects of
selegiline on motivational complications.
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Social environments, especially mother-infant synchrony during
childhood, have a critical role in shaping the brain and behavior [1]. Pre-
vious studies have demonstrated that the quality of early life is strongly
associated with psychological well-being in adulthood [2,3]. Adversity
in the neonatal stage of life dramatically disturbs neuronal and brain de-
velopment and subsequently affects an infant's physical and/or psycho-
logical health [4,5]. Growing body of evidence indicates that exposure to
stress, especially during the neonatal period, enhances the risk of neuro-
psychiatric states, including mood and depressive disorders in later life
[6,7]. In this regard, it has been shown that experiencing early psycho-
logical stress such as maternal separation (MS) through alterations in
neurotransmission in various regions of the brain induces psychiatric
disorders, including depression [8–10].
Aversive emotional experience during infancy negatively impacts
the structural and functional development of limbic brain circuits [11].
Maternal care, such as licking and grooming, stimulates the developing
mesolimbic dopaminergic system which leads to an increase in dopa-
mine levels as well as dopaminergic receptors [12]. In this regard, it is
well-known that MS leads to neurotransmitter changes in the brain es-
pecially in the mesocorticolimbic dopamine neurotransmission
[13–15]. Maternal separation stress has been shown to induce poten-
tially enduring changes in the density of dopamine receptors as well
as lasting derangements in dopamine neurotransmission in the brain
[3,14]. Previous studies have demonstrated that MS affects dopaminer-
gic circuits through an increase in levels of glucocorticoids (GC) [16,17].
Dopamine is an important neurotransmitter involved in a number of
brain functions such as emotion, reward and behavior, as well as the
neuropsychiatric disorders such as depression [18] [19,20]. Depressive
disorder is a debilitatingmental disorderwith high prevalence, morbid-
ity, and costly socioeconomic burden [21]. Anhedonia and motivational
impairments are major symptoms of depressive disorder which are as-
sociated with reward pathway deregulations. It has been shown that
dopamine is associated with motivation, reward and hedonia states.
Therefore, increasing dopamine levels may be considered as an avenue
for the treatment of depression [19,22,23]. It has been well established
that dopamine agonists improve depressive symptoms [24]. In this re-
gard, ample evidence suggested that dopamine D1 receptor mediated
the effects of antidepressant drugs in the forced swim test (FST),
while other studies demonstrated that dopamine D2 receptor antago-
nists blocked the effect of antidepressant drugs in the FST [25,26].
Selegiline [(−)-deprenyl] is an irreversible monoamine oxidase
(MAO) type B inhibitor, an enzyme involved in dopamine metabolism
[27]. It has been shown that selegiline increased striatal dopamine
levels, and signiﬁcantly improved a whole variety of depressive symp-
tomatologies [28]. Since selegiline is metabolized to (−)-methamphet-
amine and (−)-amphetamine, the effects of drug on dopamine levels in
the brain may be due to its amphetamine-like action [29]. Considering
that selegiline possesses antidepressant effects and also potentiates
the effects of antidepressants, there could be possible uses for selegiline
in the management of resistant depression [30–32].
Although selegiline has antidepressant effects by increasing the
striatal dopamine levels, role of D1 and D2 dopaminergic receptors are
ambiguous in these effects. Using MS paradigm, this study aimed to ex-
plore the role of D1 and D2 receptors in the behavioral tests relevant to
depressive-like behaviors in male mice.
2. Materials and methods
2.1. Animals
Pregnant NMRI mice (Pasteur Institute, Tehran, Iran) were used in
this study. Animals were maintained under standard laboratory condi-
tions (12-h light/dark cycle, temperature (22 ± 1 °C) and free access
to food and water). The day of birth was considered as postnatal day 0(PND 0). The litters were subsequently assigned to the MS paradigm.
In this regard, pups were brieﬂy handled and separated from their
mothers for 180 min daily during PND 2 to PND 14, beginning at
09:00 a.m. [33,34]. At the end of the separation period pups were
returned to the nest cage. At PND 21, male offspring were housed in
groups until experiment day PND 50.
All procedures in this study were carried out in accordance with the
National Institutes of Health (NIH) Guide for the Care and Use of Labo-
ratory Animals (NIH publication # 80-23) and institutional guidelines
for animal care and use (Department of Pharmacology, School of Medi-
cine, TUMS). All experiments were conducted between 10:00 a.m. and
02:00 p.m. Each experimental group consisted of 6 to 8 animals.
2.2. Drugs
The drugs used in this study were as follows: 1) selegiline hydro-
chloride: MAO-B inhibitor, 2) sulpiride (SULP): dopamine D2 receptor
antagonist, and 3) SCH 23390 (SCH): dopamine D1 receptor antagonist.
All drugs were purchased from Sigma, St Louis, MO, USA. All drugs were
dissolved in 0.9% saline in a volume of 10ml/kg. SULP and SCHwere ad-
ministered intraperitoneally (i.p.), whereas selegiline hydrochloride
was administered via subcutaneous route (s.c) injections. Doses of
each drugwere selected based on previous published studies by Binfaré
et al. and Shimazu et al. [25,35] and our own pilot studies. We treated
mice with selegiline hydrocloride (60 min), SULP and SCH (90 min)
prior to behavioral experiments. Dosing calculations were determined
using the weight of the compound (including its salt). The dose of
each drug was adjusted according to animal body weight (mg of
drug/kg of body weight of mice).
2.3. Study design
Behavioral experiments consisted of open ﬁeld test (OFT), forced
swimming test (FST), splash test and sucrose preference test (SPT)
which were conducted using control or MS mice as follows:
Experiment 1 tested the effects of the early stress experience,MS, on
the different behavioral tasks related to assessing depressive-like
behaviors.
Experiment 2 examined the effect of selegiline hydrochloride (1, 3,
and 5 mg/kg) on depressive-like behaviors using behavioral tasks. Ani-
mals in this experiment received selegiline hydrochloride 60min before
the behavioral tests.
In experiment 3, we examined the effect of selegiline hydrochloride
(3 mg/kg) along with SCH (0.03 mg/kg) or SULP (50 mg/kg) on
depressive-like behaviors by using behavioral tasks. Animals in this
trial received SCH or SULP 30 min prior to selegiline injection and
90 min before the tests.
2.4. Forced swimming test (FST)
The FSTwas carried out according to the previously describedmeth-
od by Porsolt et al. and Cryan et al. [36,37]. In this behavioral test, ex-
tended immobility time represents despair behavior reﬂecting
depressive-like symptoms. Mice were separately placed in an open
cylinder-shaped ﬂask (diameter 10 cm, height 25 cm), containing
19 cm water at 23 ± 1 °C. Mice were permitted to swim for 6 min and
the period of immobility was recorded throughout the last 4 min of
the test. Each mouse was judged to be immobile when it ceased strug-
gling and stayed ﬂoating motionless in the water and making only
those movements necessary to keep its head above water.
2.5. Open ﬁeld test (OFT)
The OFT was used to illuminate the effects of MS and treatments on
motor function, exploratory behavior, and to rule out possible alter-
ations in locomotion that might affect FST [38]. The OFT apparatus
Fig 1. Effects ofMS on the immobility time in the FST (A), grooming activity in the splash test (B), the percentage of sucrose consumption in the SPT (C), and the horizontal activity (D) and
vertical activity (E) in the OFT. Values are expressed as the mean ± S.E.M from 6 to 8 animals and were analyzed using t-test. ***P b 0.001 compared with the control mice.
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was dimly illuminated. Each mouse was placed gently on the central
zone (30 cm × 30 cm) and its behaviors were recorded by a camera
for 5 min and analyzed by Ethovision software version 8 (Noldus,
Netherlands). The distancemoved (horizontal activity) and the number
of rearings (vertical activity) were evaluated. The apparatus was
cleaned with 70% ethanol after testing each mouse.
2.6. Splash test
Splash test was used to assess motivational and self-care difﬁculties,
which indicates depressive-like behaviors in animals [39]. Lack of moti-
vation and self-care behaviors, as the symptoms of depression, is deter-
mined by a reduction in grooming activity time. In this behavioral test,
the grooming activity of mice including nose/face grooming, head
washing and body grooming, which considered as an indirect measure
of pleasant solution intake, was recorded. A 10% sucrose solution was
spurted on the dorsal coat of animals in their home cage and was ani-
mals were ﬁlmed for 5 min. The total grooming activity time was re-
corded during 5 min after the sucrose vaporization.
2.7. Sucrose preference test (SPT)
The SPTwas applied to estimate the hedonic state in animals follow-
ing a protocol previously described byWallace et al. [40]. In this regard,
two bottles of tapwater were introduced to animals by placing one bot-
tle in the home cage of each mouse for the ﬁrst two days. Then, for the
second two days one of the bottles was replaced by a bottle containing
1% sucrose solution. On the test day, animals were deprived of food and
water for ﬁve hours and then sucrose preference was assessed during
one hour of liquid consumption using two bottles in each cage, one of
1% sucrose solution and one of tap water. SPT was measured using the
following equationwhich evaluates the ratio of 1% sucrose solution con-
sumed to the total liquid consumed: sucrose preference= sucrose con-
sumed / (sucrose consumed + tap water consumed).
2.8. Statistical analysis
Comparison between groupswas analyzed using t-test and one-way
ANOVA followed by Tukey's post hoc test. P b 0.05 was considered sta-
tistically signiﬁcant. The sample size was calculated by powercalculations using G power software (ver.3.1.7, Franz Faul, Universitat
Kiel, Germany). We set α error at 0.05 and power (1-β) at 0.8 and the
required total sample size per groupwas calculated as 6–8 in behavioral
tests. We also calculated the power value in each experimental group
and analyses have shown that the power values were larger than 0.8
in all ANOVA analyses. The effect size for the both ANOVA and t-test
analyses were calculated by the Cohen's formula [41].
3. Results
3.1. Effects of MS on the depressive-like behaviors
Our t-test analysis revealed that the MS paradigm induced
depressive-like behaviors in MS mice when compared to control ani-
mals. In the FST, MS mice showed an increase in the immobility time
in comparison with normal animals (P b 0.001, Fig. 1A, effect size:
4.48). Results show that MS caused a signiﬁcant reduction in grooming
activity time in the splash test when compared to control animals
(P b 0.001, Fig. 1B, effect size: 18.302). Furthermore, SPT ﬁndings
show that, MS signiﬁcantly reduced sucrose consumption in compari-
son with control group (P b 0.001, Fig. 1C, effect size: 3.821). In the
OFT, MS signiﬁcantly increased the total distancemoved (horizontal ac-
tivity) (P b 0.001, Fig.1D, effect size: 5.864) and number of rearings (ver-
tical activity) (P b 0.001, Fig.1E, effect size: 5.864) in comparison to
control mice.
3.2. Effects of selegiline on the depressive-like behaviors in animals
In order to determine the effective dose of selegiline, we assessed
the effects of various doses of selegiline (1, 3 and 5 mg/kg, s.c.) on
depressive-like behaviors in both MS and control mice using the
above-mentioned tests. One-way ANOVA analysis demonstrated that
treatment with selegiline (5 mg/kg) produced signiﬁcant alterations
in depressive-like behaviors in control mice when compared with
saline-treated control mice in the FST (P b 0.001, Fig. 2A, effect size:
0.902), splash test (P b 0.001, Fig. 2B, effect size: 0.982), and in the SPT
(P b 0.05, Fig. 2C, effect size: 0.870). However, doses of 1 and 3 mg/kg
of selegiline had no effect in the aforementioned behavioral tests in con-
trol mice. In addition, selegiline (1, 3 and 5 mg/kg) produced no signif-
icant changes in horizontal and vertical activities in the OFT in control
mice (Fig. 2D, effect size: 0.893 and Fig. E, effect size: 0.798). One-way
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and 5 mg/kg signiﬁcantly changed the depressive-like behaviors in MS
mice in the FST(P b 0.001 and P b 0.001, Fig. 2A), splash test (P b 0.001
and P b 0.001, Fig. 2B), and SPT (P b 0.05 and P b 0.01, Fig. 2C). In the
OFT, Tukey's post-hoc analysis showed that administration of selegiline
(3 and 5 mg/kg, but not 1 mg/kg) to MS mice signiﬁcantly decreased
horizontal activity in comparison with saline-treated MS mice
(P b 0.01 and P b 0.01, Fig. 2D). However, MS mice did not signiﬁcantly
respond to selegiline (1, 3 and 5 mg/kg) in vertical activity in OFT.
3.3. Anti-depressant effects of selegiline mediated via D1 and D2 dopamine
receptors
One-way ANOVA analysis revealed that treatment of MS mice with
selegiline (3 mg/kg) signiﬁcantly reduced the immobility time in FST
in comparison with saline-treated MS mice (P b 0.001, Fig. 3A, effect
size: 0.892). Co-administration of SCH (0.03 mg/kg) with selegiline
(3 mg/kg) in MS mice signiﬁcantly increased the immobility time in
comparison with saline-treated counterpart (P b 0.05). The administra-
tion of SULP (50 mg/kg) plus selegiline signiﬁcantly decreased the im-
mobility time when compared to saline + MS counterpart (P b 0.001).
The results of the FST revealed that unlike SULP + selegiline, pretreat-
ment with SCH signiﬁcantly reversed the effect of selegiline on the im-
mobility time in comparison with selegiline- treated MS group
(P b 0.001). Splash test results show that selegiline (3 mg/kg) signiﬁ-
cantly increased the grooming activity time in MS mice in comparison
with saline-treated mice (P b 0.001, Fig. 3B, effect size: 0.985). Co-Fig. 2.Effect of selegiline (1, 3, and 5mg/kg) treatment on the immobility time in the FST (A), gro
and the horizontal activity (D) and vertical activity (E) in the OFT inMS and control animals. Va
way ANOVA followed by Tukey's post hoc test. ⁎P b 0.05 and ⁎⁎⁎P b 0.001 compared with the sa
treated MS mice.administration of SULP with selegiline signiﬁcantly decreased the
grooming activity time in comparison with saline-treated MS counter-
part (P b 0.01). Theﬁndings of the splash test showed that pretreatment
with SCH or SULP signiﬁcantly reversed the effect of selegiline on the
grooming activity time in comparison to selegiline- treated MS mice
(P b 0.001 for both). Also, when compared with the saline-treated MS
mice, we found that selegiline (3mg/kg) signiﬁcantly increased sucrose
consumption in the MS group (P b 0.05, Fig. 3C, effect size: 0.900). Co-
administration of SULP with selegiline signiﬁcantly decreased sucrose
intake in MS mice when compared to saline-treated MS mice
(P b 0.05). The results of SPT showed that co-administration of SULP
with selegiline signiﬁcantly decreased sucrose consumptionwhen com-
pared to selegiline-treated MS mice (P b 0.001). One-way ANOVA anal-
ysis demonstrated that treatment with selegiline (3 mg/kg) alone or in
combination with SCH and/or SULP produced no signiﬁcant alterations
in depressive-like behaviors in control mice in comparison to saline-
treated or selegiline-treated control mice in the FST, splash test and SPT.
Furthermore, Fig. 3D (effect size: 0.824) and Fig. 3E (effect size:
0.804) show that treatment with selegiline (3 mg/kg) alone or plus
SCH and/or SULP produce no signiﬁcant changes either in horizontal
or vertical activities in the OFT when compared to their saline/
selegiline-treated counterparts in both MS and control mice.
4. Discussion
The results of the present study showed thatMS, as an accepted par-
adigm of early life stress, provoked behaviors relevant to depression inoming activity in the splash test (B), the percentage of sucrose consumption in the SPT (C),
lues are expressed as themean± S.E.M from 6 to 8 animals andwere analyzed using one-
line-treated control mice, #P b 0.05, ##P b 0.01 and ###P b 0.001 compared with the saline-
Fig. 3. Involvement of D1 andD2dopamine receptors in antidepressant effects of selegiline on the immobility time in the FST (A), grooming activity in the splash test (B), the percentage of
sucrose consumption in the SPT (C), and the horizontal activity (D) and vertical activity (E) in the OFT in MS and control animals. Values are expressed as the mean ± S.E.M from 6 to 8
animals and were analyzed using one-way ANOVA followed by Tukey's post hoc test. ⁎P b 0.05, ⁎⁎P b 0.01 and ⁎⁎⁎P b 0.001 compared with the saline-treated control mice, #P b 0.05,
##P b 0.01 and ###P b 0.001 compared with the saline-treated MS mice, &&&P b 0.001 compared with the selegiline (3 mg/kg)-treated MS mice.
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selegiline treatment. Furthermore, our results showed that the antide-
pressant effects of selegiline on passive behaviors in the FSTmay beme-
diated via D1 receptors. Further, we found that D2 receptors mediate
the effects of selegiline on motivation, self-care behaviors and hedonic
state.
Maternal–newborn contact has a key role in the organization of an
infant's physiological systems as well as development of the brain.
Ample evidence indicates that early maternal contact is associated
with bio-behavioral development which stimulates shaping of physio-
logical and behavioral processes, and enhances social adaptation
[42–44]. In contrast, previous investigations have demonstrated that
early maternal separation causes enduring negative effects on brain
and behavior [45]. Clinical studies have reported that maternal care
may be considered as a parameter for prediction of social maturity in
adolescence among children at risk of depression [46]. In this study,
our results demonstrated that experiencing MS stress during P2-P14 is
associated with the development of depressive-like behaviors in adult
male NMRI mice. It is important to note that there are several factors
that can affect the results following an MS paradigm. In this regard,
there is evidence indicating that strain differences and differentMS par-
adigms are able to change experiment outcomes [47,48]. As stated
above,we applied aMS paradigm that has been shown to induce behav-
ioral abnormalities in animals in previous studies [33,34]. Further, we
used NMRI mice in this study primarily because results obtained in
our laboratory and others have shown that this strain is sensitive to ef-
fects of social stressors such as adolescent social isolation, social defeat,
maternal separation, and chronic mild stresses [49–54].
A large body of evidence has demonstrated that MS stress is able to
alter neurotransmission in the various regions of the brain, and these
changes are associated with the development of mood and anxiety dis-
orders [8–10]. The results of our study are in line with previous reports
indicating that the MS paradigm negatively evokes behaviors relevant
to depression [5,7]. In this context, our behavioral testing showed that
MSmice exhibited an increase in immobility time, as a passive behavior
in the FST, similar to behavioral despair as a core symptom observed in
human depression [37]. The splash test is an accepted method evaluat-
ing the self-care difﬁculties and motivation in rodents [55]. MS mice
showed a poor response to sucrose 10% (decrease in the grooming
time) indicating a disruption in motivation and self-care behaviors. It
is well established that SPT is a valid test for evaluating the anhedonia
in animals [40]. In this regard, our ﬁndings were validated by develop-
ment an anhedonic state (reduction in sucrose consumption) of MS
mice in the SPT indicating that MS is able to induce anhedonia in ani-
mals [56]. OFT was applied immediately before the FST to evaluate am-
bulatory behavior of mice and also conﬁrm that variations which occur
in motor activity did not affect the duration of immobility [57]. In the
OFT, MS mice showed an increase in locomotion in both vertical and
horizontal activities. In the case of OFT, it should be noted that there is
an inconsistency in the literature regarding OFT results following MS
paradigm. In this regard, previous studies reported that MS decreases
locomotion [48], increases locomotion [58] or do not change ambula-
tion in the OFT [59].
While there are concerns about the cogency of FST, this test is a valid
and rapid screening test for assessment of new antidepressant agents. It
has been well established that depressed patients have difﬁculties deal-
ing with stressful conditions and, similarly, depressed rodents behave
the same in the stressful conditions (cylinder ﬁlled with water) by
exhibiting passive behaviors [37,60]. In this study, we also applied the
splash test and SPT as valid tools to assess motivation and self-care be-
havior aswell as hedonic state in animals [55,61]. Moreover, an increase
in the number of rearings (vertical activity) and distance traveled (hor-
izontal activity) by MS mice in the OFT validated our FST results.
Experiencing psychological adversity in infancy has a negative inﬂu-
ence on the development of mesolimbic dopaminergic system [16,52,
62–64]. Evidence is accumulating that MS leads to neurotransmitterchanges in the brain. In this regard, it has been shown that MS induces
long-lasting alterations in the dopaminergic system of the central ner-
vous system [65–67]. Dopamine is an important monoamine involved
in emotion, reward and behavior as well as depression [19]. Hedonia
and motivational impairment along with despair behavior are major
symptomsof depressive disorderwhich are associatedwith dysfunction
of the reward pathway [68,69]. Regarding the involvement of dopamine
in motivational and hedonic behaviors, those agents which are capable
of enhancing dopaminergic activity may potentially have antidepres-
sant properties [70].
On the other hand, it is well determined that selegiline [(−)-depre-
nyl], an irreversible monoamine oxidase (MAO) type B inhibitor, in-
creased striatal dopamine levels and possess antidepressant activity
[28,31]. In this context, our results showed that administration of
selegiline improved depressive-like behaviors. Following treatment
with selegiline in MS mice, the immobility time decreased in the FST,
grooming time increased in the splash test as amount of sucrose intake
enhanced in the SPT. OFT revealed that selegiline decreased the hori-
zontal activity of MS mice.
In order to determine the role of D1 and D2 dopaminergic receptors
in antidepressant effects of selegiline, using SCH (D1 antagonist) and
SULP (D2 antagonist) we showed that co-administration of SCH with
selegiline increased immobility time in MS mice, while no change was
observed in the splash test and SPT. This indicates that the antidepres-
sant effects of selegiline on passive behavior in the FST are mediated
via D1 receptor. Our ﬁndings show that blocking of D2 receptors by pre-
treatment with SULP reversed the effects of selegiline in the splash test
and SPT inMSmice. This suggests that the effect of selegiline on themo-
tivational and self-care behaviors as well as hedonic state is mediated
through D2 receptors. Previous studies have demonstrated that D1 re-
ceptors mediate the antidepressant effects of drugs in the FST, whereas
D2 receptor antagonists are reported to have an antagonistic effect on
the antidepressant like effect of drugs in the FST [25,26]. Our results
are in line with studies that demonstrated that D2 receptor is not asso-
ciated with behaviors in the FST, but are associated with hedonic and
motivation behaviors [25,71]. Furthermore, both D1 and D2 receptor
antagonists have been reported to antagonize the therapeutic effects
of antidepressants [72–74]. In this regard, a recent study by Li et al. dem-
onstrated that dopamine receptors contribute to the rapid
antidepressant-like effects of ketamine in the FST [75]. In addition, the
acute antidepressant-like effects of selegiline have been reported in
the FST. In this context, Shimazu and colleagues reported that the
acute antidepressant-like effects of selegiline in the FST is associated
with activation of D1 receptors and not MAO-B inhibition. Also, they
demonstrated that acute effects of selegiline may be related to its
main metabolite (−)-methamphetamine. Our results are in agreement
with this previous study and demonstrate that acute effects of selegiline
are mediated by dopaminergic system [25].
The antidepressant effects of selegiline have been well documented
in the literature, however there is no information on the contribution of
D1 andD2 dopamine receptors on the antidepressant effect of selegiline
[30,76]. In the current study, we have shown that D1 receptors mediate
the antidepressant-like effect of selegiline in the FST (passive behavior).
Moreover, effects of selegiline on self-care behavior and hedonic state in
the splash test and SPT are mediated through D2 receptor. Indeed, MS
stress is associated with poor development of reward pathways, specif-
ically in male pups that makes them susceptible to many challenges in
later life such as addictive behaviors as well as psychiatry disorders.
On the other hand, selegiline is known to improve the performance of
dopaminergic system in people with Parkinson's disease. Because this
compound is actively converted to L-amphetamine in the body, we hy-
pothesized that maybe the antidepressant effects of selegiline is associ-
ated with its ability to enhance the activity of dopaminergic system,
which speciﬁcally are affected by MS stress. After results of this study,
we also applied chronic selegiline to maternally separated rats during
their adolescent period, and we observed interesting results and we
113S. Amiri et al. / Physiology & Behavior 163 (2016) 107–114found advantageous effects of selegiline are associated with its effects
on mitochondrial function and other parameters in the brain. However,
in case of behavioral tests, we observed that effects of selegiline areme-
diated by dopaminergic system in a speciﬁc manner (unpublished
data).
5. Conclusion
In conclusion, the results of our study show that: 1) experiencingMS
in early life provoked depressive-like behaviors in adult male mice,
2) selegiline exerts antidepressant properties in MS mice, 3) D1 dopa-
mine receptors facilitate the positive effect of selegiline on despair be-
havior in the FST, 4) the antidepressant effects of selegiline on
motivational difﬁculties may bemediated via both D1 and D2 receptors
in the splash test, and 5) D2 receptors may be involved in the protective
effects of selegiline against anhedonia problems in the SPT.
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